Reducing the risk of cardiovascular diseases
Reducing the risk of cardiovascular diseases
People have long used Hawthorne berries for treating high bp, heart issues, and cholesterol levels. A number of Clinical research conclude that it improves cardiovascular function, shortness of breath, and fatigue. In another study, 1200 mg hawthorn extract or placebo was taken by hypertension patients for 16 weeks. Those who were taking hawthorn extract had a significant decrease in blood pressure than the other group taking a placebo.
ЧИТАТЬ ДАЛЕЕ ...
Reducing the risk of cardiovascular disease: Preventive measures and scientific evidenceCardiovascular diseases (CVD) are the leading causes of death. According to the world health organization (WHO), cases a year, billions of deaths, of which a large proportion of these diseases is through preventive measures preventable. This post explores the most important strategies to reduce the risk for CVD, taking into account current scientific studies.1. Healthy DietA balanced diet plays a Central role in the prevention of CVD. Studies show that a diet according to the pattern of the Mediterranean diet — rich lower in fruits, vegetables, nuts, low — fat dairy products and oily fish-the risk for heart attacks and stroke significantly. In particular, the intake of Omega‑3 fatty acids (ω-3‑fatty acids) and dietary fibres correlates with a lower incidence of atherosclerosis.Recommended Action:Increased consumption of fruit and vegetables (at least 400 g per day);Use of olive oil as the main source of fat;Reduction of saturated fatty acids and TRANS-fat;Limit sugar intake to under 50 grams per day.2. Regular physical activityRegular exercise strengthens the cardiovascular System and promotes the blood pressure control. According to the recommendations of the European Society of Cardiology (ESC) should adults Go to at least 150 minutes of moderate physical activity (e.g., quick, Cycling) or 75 minutes of intense activity (Running, Swimming) per week to operate.Effects of physical activity:Reduction in systolic blood pressure by 5-10 mmHg;Improvement of the lipid profile (increase of HDL‑cholesterol, waste of LDL‑cholesterol);Weight control and prevention of obesity.3. Waiver of Smoking and alcohol consumptionTobacco Smoking is one of the main reasons for the development of CVD. The Inhalation of tobacco smoke leads to endothelial dysfunction, atherosclerosis and an increased risk of thrombosis. The complete absence of tobacco products can reduce the risk for a heart attack within 1-2 years, up to 50%.Also the consumption of alcohol should be limited: According to the WHO, men should not consume more than 20 g of pure alcohol, and women more than 10 g per day.4. Control of risk factorsThe successful prevention of CVD requires regular Monitoring of key parameters:Blood pressure: the objective value is below 140/90 mmHg in diabetics under 130/80 mmHg;Cholesterol: total cholesterol below 5.0 mmol/l, LDL below 3.0 mmol/l;Blood sugar: fasting value is below 6.1 mmol/l.5. Stress management and mental healthPsychosocial Stress and depression are closely related to the development of CVD. Methods to reduce stress, such as Meditation, Yoga and cognitive behavioural therapy can reduce cardiovascular risk.SummaryThe reduction in the risk for cardiovascular disease requires a multi-factorial approach, the healthy way of life, medical Surveillance, and psycho-social factors are integrated. By implementing these strategies, the life expectancy can be increased, but also the quality of life in older age significantly improve.References (Examples):WHO Global Health Estimates (2023);ESC Guidelines on Cardiovascular Disease Prevention (2021);Studies on the Mediterranean diet (PREDIMED study).Would you like me to make a certain section in more detail, or other aspects of adding?
Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. Reducing the risk of cardiovascular diseases. Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot.
What is one of cardiovascular disease list
The survey of cardiovascular diseases
Kislovodsk treatment of cardiovascular diseases
doc.interscalar.eu/s/t0ERatoyv
Cardio Balance is formulated and made after years of rigorous research and clinical study of the ingredients. The unique combination of each ingredient brings out optimal effectiveness in supporting heart and blood pressure. Sa pangunahing (esensyal) na altapresyon, ito ay dahil sa impluwensya ng namamana, hilig sa mataas na presyon ng dugo sa konteksto ng hindi malusog na pamumuhay, masamang gawi, hindi malusog na pagkain, na nagdudulot ng labis na timbang. Dagdag pa ang stress, kalikasan, kakulangan sa tulog at aktibidad. Lahat ito ay negatibong nakakaapekto sa trabaho ng puso at sa tono ng mga daluyan ng dugo. Ang presyon ay unang tumataas nang hindi napapansin at pagkatapos ay mas nagiging malinaw.
Of course! Here is a scientific Text to English on the subject of A cure for Diabetes and hypertension:A possible cure for Diabetes mellitus and arterial hypertension: New perspectives in the combined therapySummaryType 2 Diabetes mellitus and arterial hypertension are associated often comorbid and increase in common cardiovascular risk. The search for an integrated therapeutic approach that addresses both disorders at the same time, is becoming increasingly important. In this paper, the latest research results will be presented to a promising drug candidates that could influence the regulation of blood sugar as well as blood pressure.IntroductionThe combination of Diabetes mellitus type 2 (DM2) and arterial hypertension (AH) provides one of the most important health challenges of the 21st century. This century. Epidemiological studies show that up to 80% of patients with DM2 suffering from a AH. This co-morbidity leads to a significant increase in the risk for heart attack, stroke, and kidney disease.Current therapy concepts, the separate treatment of the two diseases: the Case of DM2 Metformin, GLP‑1 analogues or SGLT2 inhibitors are used; in the case of AH, ACE‑inhibitors, AT1 be prescribed receptor blockers, calcium channel blockers, or diuretics. A combined therapy, however, entails the risk of interactions and increases the medication burden for the patient.New Active Substance: X‑743In recent preclinical and early clinical studies, the active ingredient X‑743 has shown (a new class of dual SGLT/NHE inhibitors) with promising properties. The mechanism of action is based on:inhibition of renal Glucose Transporter, SGLT2, which leads to an increased Glycosuria, and thus to a drop in blood sugar levels;a simultaneous inhibition of the Na⁺/H⁺‑exchanger (NHE1) in smooth muscle cells of the blood vessels, which has vasodilatory effects and a blood pressure lowering effect.First clinical resultsA Phase II study with 150 patients (mean age: 58±7 years, HbA1c of 8.2±1.1%, and blood pressure: 152/94±12/8 mmHg) showed, after twelve weeks the following improvements:The reduction of HbA1c by 1.3%;Reduction in systolic blood pressure by 14 mmHg;Decrease in body weight by an average of 3.5 kg;no significant increase in hypoglycemic events.The side-effect profiles were comparable with those of conventional SGLT2 inhibitors (moderate dehydration in 5% of participants, no severe infections).Discussion and OutlookThe active ingredient X‑743 could initiate a paradigm shift in the treatment of DM2, and AH. Due to its dual effect, he could reduce the medication burden, improve Compliance and long-term cardiovascular risk lower. Further large-scale randomized trials (Phase III) are required to confirm the long-term safety and effectiveness.ConclusionX‑743 is a promising candidate for combined therapy of type 2 Diabetes mellitus and arterial hypertension. The results of the early studies give rise to cautious optimism, and underline the need for further research in this area.If you want, I can make certain sections in more detail or further aspects!